These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Preparation, Characterization, and In Vitro Evaluation of Lipidoid-Polymer Hybrid Nanoparticles for siRNA Delivery to the Cytosol. Thanki K; Zeng X; Foged C Methods Mol Biol; 2019; 1943():141-152. PubMed ID: 30838614 [TBL] [Abstract][Full Text] [Related]
25. Assessment of In Vivo siRNA Delivery in Cancer Mouse Models. Hatakeyama H; Wu SY; Mangala LS; Lopez-Berestein G; Sood AK Methods Mol Biol; 2016; 1402():189-197. PubMed ID: 26721492 [TBL] [Abstract][Full Text] [Related]
26. Powering up the molecular therapy of RNA interference by novel nanoparticles. Liao W; Li W; Zhang T; Kirberger M; Liu J; Wang P; Chen W; Wang Y Biomater Sci; 2016 Jun; 4(7):1051-61. PubMed ID: 27221980 [TBL] [Abstract][Full Text] [Related]
27. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles. Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198 [TBL] [Abstract][Full Text] [Related]
28. Stealth magnetic nanocarriers of siRNA as platform for breast cancer theranostics. Bruniaux J; Djemaa SB; Hervé-Aubert K; Marchais H; Chourpa I; David S Int J Pharm; 2017 Nov; 532(2):660-668. PubMed ID: 28506802 [TBL] [Abstract][Full Text] [Related]
29. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy. Ku SH; Kim K; Choi K; Kim SH; Kwon IC Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795 [TBL] [Abstract][Full Text] [Related]
30. Ultra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer Efficacy. Xu X; Wu J; Liu Y; Yu M; Zhao L; Zhu X; Bhasin S; Li Q; Ha E; Shi J; Farokhzad OC Angew Chem Int Ed Engl; 2016 Jun; 55(25):7091-7094. PubMed ID: 27140428 [TBL] [Abstract][Full Text] [Related]
31. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice. Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295 [TBL] [Abstract][Full Text] [Related]
32. Polyethyleneimine-based core-shell nanogels: a promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells. Mimi H; Ho KM; Siu YS; Wu A; Li P J Control Release; 2012 Feb; 158(1):123-30. PubMed ID: 22094103 [TBL] [Abstract][Full Text] [Related]
33. Efficient intracellular delivery of siRNA with a safe multitargeted lipid-based nanoplatform. Gomes-da-Silva LC; Fernández Y; Abasolo I; Schwartz S; Ramalho JS; Pedroso de Lima MC; Simões S; Moreira JN Nanomedicine (Lond); 2013 Sep; 8(9):1397-413. PubMed ID: 23394132 [TBL] [Abstract][Full Text] [Related]
34. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy. Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077 [TBL] [Abstract][Full Text] [Related]
35. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery. Chen G; Wang Y; Xie R; Gong S J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516 [TBL] [Abstract][Full Text] [Related]
36. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers. Joo MK; Yhee JY; Kim SH; Kim K J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319 [TBL] [Abstract][Full Text] [Related]
37. Stimuli-Responsive Polymer-Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy. Saw PE; Yao H; Lin C; Tao W; Farokhzad OC; Xu X Nano Lett; 2019 Sep; 19(9):5967-5974. PubMed ID: 31381852 [TBL] [Abstract][Full Text] [Related]
38. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges. Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781 [TBL] [Abstract][Full Text] [Related]
39. Polyethylenimine nanoparticles as an efficient in vitro siRNA delivery system. Nimesh S; Chandra R Eur J Pharm Biopharm; 2009 Sep; 73(1):43-9. PubMed ID: 19362592 [TBL] [Abstract][Full Text] [Related]
40. The role of disulfide-bridge on the activities of H-shape gemini-like cationic lipid based siRNA delivery. Ma XF; Sun J; Qiu C; Wu YF; Zheng Y; Yu MZ; Pei XW; Wei L; Niu YJ; Pang WH; Yang ZJ; Wang JC; Zhang Q J Control Release; 2016 Aug; 235():99-111. PubMed ID: 27242198 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]